Cyanotech (CYAN) Given Media Sentiment Score of 0.09

Headlines about Cyanotech (NASDAQ:CYAN) have trended somewhat positive recently, according to Accern Sentiment. The research group identifies negative and positive media coverage by analyzing more than 20 million news and blog sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Cyanotech earned a news sentiment score of 0.09 on Accern’s scale. Accern also gave news stories about the biotechnology company an impact score of 44.9748869205227 out of 100, meaning that recent media coverage is somewhat unlikely to have an impact on the company’s share price in the near term.

Shares of Cyanotech (NASDAQ:CYAN) remained flat at $$3.80 during trading hours on Friday. 4,290 shares of the stock traded hands, compared to its average volume of 2,815. The firm has a market cap of $21.54, a PE ratio of 63.33 and a beta of 1.06. Cyanotech has a 52-week low of $3.25 and a 52-week high of $5.35. The company has a quick ratio of 0.72, a current ratio of 2.36 and a debt-to-equity ratio of 0.33.

Cyanotech (NASDAQ:CYAN) last released its quarterly earnings data on Monday, November 6th. The biotechnology company reported $0.08 EPS for the quarter. The firm had revenue of $8.06 million for the quarter. Cyanotech had a net margin of 1.11% and a return on equity of 2.06%.

Separately, ValuEngine downgraded shares of Cyanotech from a “hold” rating to a “sell” rating in a report on Friday, November 10th.

COPYRIGHT VIOLATION WARNING: This news story was first published by Ticker Report and is the property of of Ticker Report. If you are viewing this news story on another publication, it was illegally copied and reposted in violation of United States and international copyright and trademark law. The legal version of this news story can be viewed at https://www.tickerreport.com/banking-finance/3146348/cyanotech-cyan-given-media-sentiment-score-of-0-09.html.

About Cyanotech

Cyanotech Corporation is engaged in the production of natural products derived from microalgae for the nutritional supplements market. The Company’s products include Hawaiian Spirulina Pacifica and Hawaiian BioAstin. Hawaiian Spirulina Pacifica is a dietary supplement used for extra energy, a strengthened immune system, cardiovascular benefits and as a source of antioxidant carotenoids.

Insider Buying and Selling by Quarter for Cyanotech (NASDAQ:CYAN)

Receive News & Ratings for Cyanotech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cyanotech and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

How to Trade on Forex – 8 Steps for Beginners
How to Trade on Forex – 8 Steps for Beginners
Super Nintendo World Theme Park Officially Starts Construction
Super Nintendo World Theme Park Officially Starts Construction
Amazon and Apple Join Foxconn to Secure Chip Business of Toshiba
Amazon and Apple Join Foxconn to Secure Chip Business of Toshiba
Camera Zooms In and Can Recognize Faces
Camera Zooms In and Can Recognize Faces
Netflix Could See 150 Million Worldwide Subscribers
Netflix Could See 150 Million Worldwide Subscribers
LeEco Cutting Over 70% of Staff in U.S. Amidst Pull Back
LeEco Cutting Over 70% of Staff in U.S. Amidst Pull Back


© 2006-2018 Ticker Report. Google+.